an Appointment
Text
205.825.5575Call
205.825.5575Skin cancer screening is typically conducted during a formal office visit with a physician, nurse practitioner, or physician assistant (i.e., medical provider).
Patients with risk factors for skin cancer are referred to specialists for this formal procedure. During the screening office visit, patients are handed a gown or blanket and allowed to undress privately to the least clothing possible within their comfort level. During the visit, the provider follows a systematic approach to examine the entire skin, hair, and nails of the patient who is being screened. Patients who decline examination of sensitive areas of the body are advised to monitor these areas closely for new or changing lesions.
It has become standard for providers to use a portable microscopic device called a dermatoscope. Dermoscopy allows trained providers to see microscopic structures on the skin which correlate with those seen by dermatopathologists under the microscope. Dermatoscopes dramatically improve the ability of providers to detect suspicious spots earlier and to more accurately reassure patients on benign lesions. Skin biopsies are performed, with the patient’s consent, on lesions suspicious for skin cancer and the results are typically communicated to patients within 2 weeks following the visit.
Reference: US Preventive Services Task Force, Screening for Skin Cancer Recommendation Statement, JAMA, April, 2023.
Dr. Hunt grew up in Hoover, Alabama and attended Hoover High School. She started her career in business and engineering at the University of Alabama.
As an undergraduate, she gained national attention and was named "USA Today National Academic All-Star" for creating a self-sustaining peer mentoring program which measurably improved students' computer science performance at Alabama.
Her extensive work experience at Huron Consulting Group and GE Healthcare helped her realize that she would be most fulfilled in the field of medicine, helping patients one-on-one.
read more